Skip to main content

massive for research too?

. The decay of its genome mirrors an unfortunate collapse in interest in leprosy research, while disease incidence stays stubbornly high.

Written byRobert Walgate
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00

LONDON "Scientifically it's a fantastic achievement. In terms of what we will know about what it takes to become an intracellular pathogen, it's the biggest achievement for decades," said Jo Colston, Head of Mycobacterial Research at the UK's National Institute for Medical Research, in response to the publication of the genome of Mycobacterium leprae in 22 February Nature.

But at the end of 1999, the World Health Organisation (WHO) extended its deadline for the "elimination" of leprosy — meaning a reduction in the number of known cases to 1 in 10,000 within affected communities — from 2000 to 2005. The original deadline had been set in 1991 and a decade of 'elimination' strategies has led to a collapse in research funding for the disease. The European Commission, for example, awarded its last grant for leprosy research five years ago. Most mycobacterial researchers have sensibly moved over to studying tuberculosis.

This ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo